Cluster Wars: Korea’s Challenges In Shaping a Boston Style Biopharma Hub
Multiple Small Centers Create Issues
Executive Summary
South Korea has yet to come up with detailed plans for a major national biopharma cluster, but is considering a virtual approach to connect existing industry hubs nationwide. At a recent policy forum, experts discussed related issues including governance and insufficient investment, as well as the need to attract foreign firms and capital to compete with rival clusters in Asia.